Karimi M, Nilsson C, Dimitriou M, Jansson M, Matsson H, Unneberg P, Lehmann S, Kere J, Hellström-Lindberg E. High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia. Haematologica [Internet]. 2015Jun.1 [cited 2026Nov.4];100(6):e223-e225. Available from: https://haematologica.org/article/view/7418